NK/T-cell lymphoma of nasal cavity (diagnosis)

Clinical trials for NK/T-cell lymphoma of nasal cavity (diagnosis) explained in plain language.

Never miss a new study

Get alerted when new NK/T-cell lymphoma of nasal cavity (diagnosis) trials appear

Sign up with your email to follow new studies for NK/T-cell lymphoma of nasal cavity (diagnosis), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope: immune drug may replace chemo for rare nasal lymphoma

Disease control Ongoing

This pilot study tests whether the immune-boosting drug pembrolizumab can shrink early-stage NK/T-cell lymphoma in patients who have not yet had chemotherapy. Nineteen participants will receive the drug every three weeks. The goal is to see if this approach can control the diseas…

Matched conditions: NK/T-CELL LYMPHOMA OF NASAL CAVITY (DIAGNOSIS)

Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 07:55 UTC

NK/T-cell lymphoma of nasal cavity (diagnosis)

Get alerted when new NK/T-cell lymphoma of nasal cavity (diagnosis) trials appear

New hope: immune drug may replace chemo for rare nasal lymphoma